Aparito - a wholly owned subsidiary of Eli Lilly and Company

Digitising clinical trials and capturing real-world data through mobile apps, video assessments & wearable devices

Hospitals and Health Care · Wales

About

Aparito’s mission is to digitise clinical trials and accelerate drug development for patients with life-limiting diseases by supporting patient-centric clinical trials. We do this through our Atom5™ eCOA platform using video assessments, wearable devices and ePROs to generate continuous real-world data.

Details

  • Website: https://www.aparito.com/
  • Founded: 2014
  • Company Size: 30 employees
  • Headquarters: Wrexham, Wales
  • Specialties: mHealth, Wearables, Patient Engagement, Rare Diseases, Orphan Diseases, Telehealth, Digital Health, Health Technology, Decentralised Clinical Trials, Hybrid Clinical Trials, eCOA, Digital Biomarkers, ePRO, Clinical Trials, vCOA, Video eCOA